You may be right in the conspiracy theory behind the lack of success as I am only a new holder but I am sticking with the plan. Phase three trials nearly over. Why can you cross the border and have this selling and not in the USA? Yes you did mention that didn't you.
However, the house isn't on the line here, it is terribly illiquid but I do sense a slight love coming back to the biotech sector. Hopefully the company will be dragged up into that vortex?
Or down the s-bend vortex?
We patiently await the trial results.
Add to My Watchlist
What is My Watchlist?
